Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/25 16:15 | 2/18/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Messemer Deborah M. | CA | D | 1 | S | -32 | 2.43 | 0 | -13 | 144 | D | ||||||||||||||||
2/5/25 16:16 | 2/3/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Douglas Earl Martin | CA | O | SVP,GC | 1 | S | -11 | 1.71 | 0 | -6 | 588 | D | |||||||||||||||
2/5/25 16:15 | 2/3/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Parker Geoffrey M. | CA | O | CFO | 1 | S | -8 | 1.73 | 0 | -4 | 0 | 1,302 | D | ||||||||||||||
2/5/25 16:14 | 2/3/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Moore Timothy L. | CA | O | Chief Te | 1 | S | -25 | 1.71 | 0 | -15 | 251 | D | |||||||||||||||
2/5/25 16:13 | 2/3/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Chang David D | CA | DO | P,CEO | 1 | S | -77 | 1.68 | 0 | -46 | 8,230 | D | |||||||||||||||
2/5/25 16:12 | 2/3/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Roberts Zachary | CA | O | EVP of R | 2 | S | -80 | 1.75 | 0 | -46 | 643 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |